Publication | Closed Access

Application of a new anticoagulant (nafamostat mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation—A preliminary report

ThrombosisPreliminary ReportHematologyHemostasisVascular BiologyVascular TraumaCoagulopathyBleeding DisorderNew AnticoagulantMedicineAnticoagulantNafamostat MesilateAnesthesiology